Depression of contractility in cultured cardiac myocytes from neonatal rat by carbon tetrachloride and 1,1,1-trichloroethaneTORAASON, M; KRUEGER, J. A; BREITENSTEIN, M. J et al.Toxicology in vitro. 1990, Vol 4, Num 4-5, pp 363-368, issn 0887-2333, 6 p.Conference Paper

The extent and distribution of cell death and matrix damage in impacted chondral explants varies with the presence of underlying boneKRUEGER, J. A; THISSE, P; EWERS, B. J et al.Journal of biomechanical engineering. 2003, Vol 125, Num 1, pp 114-119, issn 0148-0731, 6 p.Article

Cooperative action of insulin and catecholamines on stimulation of ornithine decarboxylase activity in neonatal rat heart cellsTORAASON, M; LUKEN, M. E; KRUEGER, J. A et al.Journal of molecular and cellular cardiology. 1990, Vol 22, Num 6, pp 637-644, issn 0022-2828, 8 p.Article

Activation of furosemide-sensitive K⁺ fluxes in myocytes by ouabain and recovery from metabolic inhibitionKOHMOTO, O; KRUEGER, J. A; BARRY, W. H et al.American journal of physiology. Heart and circulatory physiology. 1990, Vol 28, Num 3, pp H962-H972, issn 0363-6135Article

L-374,087, an efficacious, orally bioavailable, pyridinone acetamide thrombin inhibitorSANDERSON, P. E. J; CUTRONA, K. J; KRUEGER, J. A et al.Bioorganic & medicinal chemistry letters (Print). 1998, Vol 8, Num 7, pp 817-822, issn 0960-894XArticle

Comparative toxicity of allylamine and acrolein in cultured myocytes and fibroblasts from neonatal rat heartTORAASON, M; LUKEN, M. E; BREITENSTEIN, M et al.Toxicology (Amsterdam). 1989, Vol 56, Num 1, pp 107-117, issn 0300-483XArticle

Design and synthesis of a series of potent and orally bioavailable noncovalent thrombin inhibitors that utilize nonbasic groups in the P1 positionTUCKER, T. J; BRADY, S. F; LYNCH, J. J et al.Journal of medicinal chemistry (Print). 1998, Vol 41, Num 17, pp 3210-3219, issn 0022-2623Article

Synthesis of a series of potent and orally bioavailable thrombin inhibitors that utilize 3,3-disubstituted propionic acid derivatives in the P₃ positionTUCKER, T. J; LUMMA, W. C; APPLEBY, S. D et al.Journal of medicinal chemistry (Print). 1997, Vol 40, Num 22, pp 3687-3693, issn 0022-2623Article

Efficacious, orally bioavailable thrombin inhibitors based on 3-aminopyridinone or 3-aminopyrazinone acetamide peptidomimetic templatesSANDERSON, P. E. J; LYLE, T. A; COOPER, C. M et al.Journal of medicinal chemistry (Print). 1998, Vol 41, Num 23, pp 4466-4474, issn 0022-2623Article

Discovery of a novel, selective, and orally bioavailable class of thrombin inhibitors incorporating aminopyridyl moieties at the P1 positionFENG, D.-M; GARDELL, S. J; LYNCH, J. J et al.Journal of medicinal chemistry (Print). 1997, Vol 40, Num 23, pp 3726-3733, issn 0022-2623Article

Olanzapine versus haloperidol in the treatment of schizophrenia and schizoaffective and schizophreniform disorders: Results of an international collaborative trialTOLLEFSON, G. D; BEASLEY, C. M; TRAN, P. V et al.The American journal of psychiatry. 1997, Vol 154, Num 4, pp 457-465, issn 0002-953XArticle